AAAAAA
Results:
1-20
|
Results: 20
Authors:
Mijatovic, V
van der Mooren, MJ
Citation: V. Mijatovic et Mj. Van Der Mooren, Homocysteine in postmenopausal women and the importance of hormone replacement therapy, CLIN CH L M, 39(8), 2001, pp. 764-767
Authors:
van der Mooren, MJ
Citation: Mj. Van Der Mooren, Cardiovascular protection by postmenopausal hormone replacement therapy - the point of lower oestrogen dosages, MATURITAS, 38(3), 2001, pp. 227-229
Authors:
Kenemans, P
van Unnik, GA
Mijatovic, V
van der Mooren, MJ
Citation: P. Kenemans et al., Perspectives in hormone replacement therapy, MATURITAS, 38, 2001, pp. S41-S48
Authors:
Post, MS
van der Mooren, MJ
van Baal, WM
Neele, SJM
Netelenbos, JC
Kenemans, P
Citation: Ms. Post et al., Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: A 2-year randomized, placebo-controlled, comparative study, AM J OBST G, 185(3), 2001, pp. 557-562
Authors:
Kessel, H
Kamp, O
Kenemans, P
Mijatovic, V
van Baal, WM
Visser, CA
van der Mooren, MJ
Citation: H. Kessel et al., Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women, AM J OBST G, 184(5), 2001, pp. 910-916
Authors:
Szulc, P
Munoz, F
Sornay-Rendu, E
Paris, E
Souhami, E
Zanchetta, J
Bagur, A
van der Mooren, MJ
Young, S
Delmas, PD
Citation: P. Szulc et al., Comparison of morphometric assessment of prevalent vertebral deformities in women using different reference data, BONE, 27(6), 2000, pp. 841-846
Authors:
van Baal, WM
Emeis, JJ
van der Mooren, MJ
Kessel, H
Kenemans, P
Stehouwer, CDA
Citation: Wm. Van Baal et al., Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study, THROMB HAEM, 83(1), 2000, pp. 29-34
Authors:
Mijatovic, V
van der Mooren, MJ
Citation: V. Mijatovic et Mj. Van Der Mooren, Menopause, oestrogens, SERM's and cardiovascular health in women, EUR J OB GY, 93(1), 2000, pp. 5-7
Authors:
Franke, HR
van de Weijer, PHM
Pennings, TMM
van der Mooren, MJ
Citation: Hr. Franke et al., Gonadotropin-releasing hormone agonist plus "add-back" hormone replacementtherapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial, FERT STERIL, 74(3), 2000, pp. 534-539
Authors:
Mijatovic, V
Kenemans, P
van der Mooren, MJ
Emeis, JJ
van Baal, WM
Peters-Muller, ER
Stehouwer, CDA
Citation: V. Mijatovic et al., Postmenopausal oestradiol-dydrogesterone therapy favourably affects fibrinolysis and Lp(a) in healthy women, FIBRINOL PR, 13(4-5), 1999, pp. 177-183
Authors:
Mijatovic, V
van der Mooren, MJ
Kenemans, P
de Walk-de Roo, GW
Netelenbos, C
Citation: V. Mijatovic et al., Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: A randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens, MENOPAUSE, 6(2), 1999, pp. 134-137
Authors:
Mijatovic, V
van der Mooren, MJ
Stehouwer, CDA
Netelenbos, JC
Kenemans, P
Citation: V. Mijatovic et al., Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection, GYNECOL END, 13(2), 1999, pp. 130-144
Authors:
van Baal, WM
Kenemans, P
van der Mooren, MJ
Kessel, H
Emeis, JJ
Stehouwer, CDA
Citation: Wm. Van Baal et al., Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women, THROMB HAEM, 81(6), 1999, pp. 925-928
Authors:
van Hoof, HJC
van der Mooren, MJ
Swinkels, LMJW
Sweep, CGJ
Merkus, JMWM
Benraad, TJ
Citation: Hjc. Van Hoof et al., Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D-3: a 1-year prospective study, CLIN ENDOCR, 50(4), 1999, pp. 511-516
Authors:
van der Mooren, MJ
Kenemans, P
Citation: Mj. Van Der Mooren et P. Kenemans, Homocysteine and fibrinolysis in acute occlusive coronary events, LANCET, 354(9188), 1999, pp. 1475-1475
Authors:
van Baal, WM
Kenemans, P
Emeis, JJ
Schalkwijk, CG
Mijatovic, V
van der Mooren, MJ
Vischer, UM
Stehouwer, CDA
Citation: Wm. Van Baal et al., Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women, FERT STERIL, 71(4), 1999, pp. 663-670
Authors:
van Baal, WM
Emeis, JJ
Kenemans, P
Kessel, H
Peters-Muller, ERA
Schalkwijk, CG
van der Mooren, MJ
Stehouwer, CDA
Citation: Wm. Van Baal et al., Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules, EUR J CL IN, 29(11), 1999, pp. 913-921
Authors:
de Valk-de Roo, GW
Stehouwer, CDA
Lambert, J
Schalkwijk, CG
van der Mooren, MJ
Kluft, C
Netelenbos, C
Citation: Gw. De Valk-de Roo et al., Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women, CLIN CHEM, 45(8), 1999, pp. 1200-1205
Authors:
van Baal, WM
Kenemans, P
Stehouwer, CDA
Peters-Muller, ERA
van Vugt, JMG
van der Mooren, MJ
Citation: Wm. Van Baal et al., Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausalwomen, AM J OBST G, 181(6), 1999, pp. 1365-1373
Authors:
Mijatovic, V
Netelenbos, C
van der Mooren, MJ
de Valk-de Roo, GW
Jakobs, C
Kenemans, P
Citation: V. Mijatovic et al., Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women, FERT STERIL, 70(6), 1998, pp. 1085-1089
Risultati:
1-20
|